Cargando…

Fairer financing of vaccines in a world living with COVID-19

Detalles Bibliográficos
Autores principales:	Megiddo, Itamar, Nonvignon, Justice, Owusu, Richmond, Chalkidou, Kalipso, Colson, Abigail, Gad, Mohamed, Klepac, Petra, Ruiz, Francis, Morton, Alec
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365434/ https://www.ncbi.nlm.nih.gov/pubmed/32665376 http://dx.doi.org/10.1136/bmjgh-2020-002951

Ejemplares similares

Mind the costs, too: towards better cost-effectiveness analyses of PBF programmes
por: Chi, Y-Ling, et al.
Publicado: (2018)

Optimal subscription models to pay for antibiotics
por: Barlow, Euan, et al.
Publicado: (2022)

COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions
por: Tagoe, Eunice Twumwaa, et al.
Publicado: (2021)

Health and economic benefits of public financing of epilepsy treatment in India: An agent‐based simulation model
por: Megiddo, Itamar, et al.
Publicado: (2016)

Application of decision analytical models to diabetes in low- and middle-income countries: a systematic review
por: Twumwaa, Tagoe Eunice, et al.
Publicado: (2022)

What do we need to know? Data sources to support evidence-based decisions using health technology assessment in Ghana
por: Hollingworth, Samantha A., et al.
Publicado: (2020)

Self-enforcing regional vaccination agreements
por: Klepac, Petra, et al.
Publicado: (2016)

Health technology assessment capacity at national level in sub-Saharan Africa: an initial survey of stakeholders
por: Hollingworth, Samantha A., et al.
Publicado: (2021)

Challenges to the delivery of clinical diabetes services in Ghana created by the COVID-19 pandemic
por: Tagoe, Eunice Twumwaa, et al.
Publicado: (2022)

Quantifying uncertainty about future antimicrobial resistance: Comparing structured expert judgment and statistical forecasting methods
por: Colson, Abigail R., et al.
Publicado: (2019)

USA stockpiling of remdesivir: How should the world respond?
por: Dawoud, Dalia, et al.
Publicado: (2020)

Let’s emerge from the pandemic lockdown into a fairer academic world
por: King, Kayla C., et al.
Publicado: (2020)

Sharing the British National Health Service around the world: a self-interested perspective
por: Chalkidou, Kalipso, et al.
Publicado: (2013)

Creating fairer futures for sustainability transitions
por: Fitzgerald, Louise M., et al.
Publicado: (2022)

The global health law trilogy: towards a safer, healthier, and fairer world
por: Gostin, Lawrence O, et al.
Publicado: (2017)

Supporting the Development of Evidence-Informed Policy Options: An Economic Evaluation of Hypertension Management in Ghana
por: Gad, Mohamed, et al.
Publicado: (2020)

Economic evaluations of health system strengthening activities in low-income and middle-income country settings: a methodological systematic review
por: Hendrix, Nathaniel, et al.
Publicado: (2022)

WHO urges countries to build a fairer, healthier world post-COVID-19
Publicado: (2021)

Maternity leave: how to make it fairer for all
por: Murrell, Dédée F.
Publicado: (2015)

Building back fairer in Greater Manchester and the country
por: Marmot, Michael
Publicado: (2021)

Biomarkers for Alzheimer's disease: Earlier, easier, and fairer
por: eBioMedicine
Publicado: (2022)

What is the value of explicit priority setting for health interventions? A simulation study
por: Barlow, Euan, et al.
Publicado: (2022)

Evaluation framework study assessing the role, applicability and adherence to good practice of planning support tools for allocation of development aid for health in low-income and middle-income countries
por: Megiddo, Itamar, et al.
Publicado: (2023)

Capacity for health economics research and practice in Jordan, Lebanon, the occupied Palestinian territories and Turkey: needs assessment and options for development
por: Gheorghe, Adrian, et al.
Publicado: (2020)

Fairer and healthier world for everyone – can lessons from the Dubrovnik Republic be applied to the COVID-19 pandemic?
por: Lukežić, Marina, et al.
Publicado: (2021)

How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?
por: Towse, Adrian, et al.
Publicado: (2021)

A Fairer Mirror: Equity-limited Healthcare System Rankings
por: Reisman, Samuel, et al.
Publicado: (2019)

Let’s Campaign for a Fairer Society in the Aftermath of COVID-19
por: Scambler, Graham
Publicado: (2022)

Caching and Reproducibility: Making Data Science Experiments Faster and FAIRer
por: Schubotz, Moritz, et al.
Publicado: (2022)

IUI needs fairer appraisal to improve patient and stakeholder choices
por: Bahadur, Gulam, et al.
Publicado: (2021)

Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact
por: Millar, Robyn, et al.
Publicado: (2021)

Evidence-informed capacity building for setting health priorities in low- and middle-income countries: A framework and recommendations for further research
por: Li, Ryan, et al.
Publicado: (2017)

Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis
por: Hollingworth, Samantha, et al.
Publicado: (2021)

The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review
por: Kazibwe, Joseph, et al.
Publicado: (2022)

Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis?
por: Culyer, Anthony J., et al.
Publicado: (2019)

Should Countries Set an Explicit Health Benefits Package? The Case of the English National Health Service()
por: Smith, Peter C, et al.
Publicado: (2017)

Organising Research and Development for evidence-informed health care: some universal characteristics and a case study from the UK
por: Culyer, Anthony J., et al.
Publicado: (2021)

A Python library for FAIRer access and deposition to the Metabolomics Workbench Data Repository
por: Smelter, Andrey, et al.
Publicado: (2018)

BioSamples database: FAIRer samples metadata to accelerate research data management
por: Courtot, Mélanie, et al.
Publicado: (2021)

The Innovative Medicines Fund: a universal model for faster and fairer access to new promising medicines or a Trojan horse for low-value creep?
por: Angelis, Aris, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_27cb6efrisqf21kip5rn356l8d